Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 2 days ago

TEVA PHARMACEUTICAL INDUSTRIES LTD: Phoenix Financial Ltd. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Phoenix Financial Ltd. amended its Schedule 13G filing on Teva Pharmaceutical Industries Ltd., updating its disclosed stake with the SEC under accession number 0001178913-26-005243. The filing does not specify the size or direction of the change in Phoenix's position. The amendment matters because Schedule 13G updates signal shifts in passive or institutional ownership that can influence Teva's shareholder base and governance dynamics. Investors will watch for further 13G or 13D filings to confirm whether Phoenix's stake is rising or being trimmed.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Teva Pharmaceutical Industries Ltd, Phoenix Financial Ltd